Desouzara, I agree with Tombeau, an acquirer will have to pay very good money to acquire PME, but everything is for sale at a price. The points you raise are correct but also make the business very appealing for one of the bigger US healthcare players looking for new product and applications growth.
Desouzara, I agree with Tombeau, an acquirer will have to pay...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$221.75 |
Change
7.130(3.32%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $216.99 | $224.65 | $215.12 | $38.21M | 172.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103 | $221.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $221.81 | 426 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
